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Objectives. The purpose of this study was to prove that tran-
sient response harmonic imaging could detect normal and abnor-
mal myocardial perfusion in multiple echocardiographic windows
with one intravenous injection of microbubbles in humans.
Background. Myocardial ultrasound contrast can be produced
from intravenous perfluorocarbon-exposed sonicated dextrose al-
bumin, and ultrasound can be significantly improved by briefly
suspending the interval between frame rates. Whether this con-
trast can noninvasively quantify myocardial perfusion in humans
is unknown.
Methods. In 28 patients, harmonic transient response imaging
was used to image the heart in multiple different imaging planes
after one intravenous injection of ultrasound contrast agent.
Twenty-five of these 28 patients had a repeat injection during
dipyridamole stress. In the primary view, the ultrasound trans-
mission rate was one frame per cardiac cycle; in secondary and
tertiary views, the transmission rate was once every multiple
cardiac cycles. Regional myocardial contrast was visually assessed
and quantified off-line. Quantitative rest thallium and dipyrida-
mole stress sestamibi imaging was also performed.
Results. Perfusion abnormalities were evident in the secondary
and tertiary views only with one frame every multiple cardiac
cycles. Regional peak myocardial videointensity (PMVI) corre-
lated closely with regional tracer uptake in individual patients
both at rest (r 5 0.84) and during stress (r 5 0.88). A PMVI ratio
(abnormal region divided by the region with highest nuclear
uptake) <0.6 in any view had a 92% sensitivity and a 84%
specificity in identifying a regional nuclear perfusion abnormality.
Conclusions. Transient response imaging produces myocardial
contrast in multiple views with one intravenous injection of
contrast agent and can accurately identify regional myocardial
perfusion abnormalities.
(J Am Coll Cardiol 1997;29:791–9)
q1997 by the American College of Cardiology
Recent data (1,2) obtained in both animals and humans
have demonstrated that visually detectable myocardial contrast
can be produced from very low intravenous doses of
perfluorocarbon-exposed sonicated dextrose albumin
(PESDA) microbubbles when ultrasound transmission rates
are reduced by triggering frame rates to once every cardiac
cycle instead of the conventional 30-Hz frame rates. This
phenomenon (referred to as transient response imaging) is
especially pronounced when using harmonic imaging (1). Be-
cause intravenously injected PESDA microbubbles containing
less soluble gases like perfluorocarbons have a delayed transit
through the lung capillaries, there is often a prolonged left
ventricular cavity contrast after one intravenous injection of
microbubbles (3). Myocardial contrast can be produced in
animals with this continuous left ventricular cavity infusion of
microbubbles long after intravenous injection by extending the
time interval between triggered frame rates to once every 5 to
10 cardiac cycles (4). This extended time interval permits the
identification of myocardial perfusion abnormalities that are
not evident with triggering just once every one cardiac cycle
and could therefore be utilized in humans to detect perfusion
abnormalities in different echocardiographic windows. The
purpose of this study was to test whether one small intravenous
injection of PESDA could produce myocardial contrast in
multiple imaging planes and correlate the degree of contrast
enhancement with myocardial perfusion determined by radio-
nuclide imaging.
Methods
Preparation of PESDA. PESDA was prepared similar to
previously described methods (1). Briefly, 8 ml of decafluoro-
butane (molecular weight 238 g/mol) was hand agitated with a
3:1 mixture of 5% dextrose and 5% human albumin. This
mixture then underwent electromechanical sonication for 80 s.
According to the manufacturer (Heat Systems Inc.) the soni-
cation process involves the transference of electrical energy to
mechanical energy (495 W). Energy output was manually
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adjusted using a digital scale during sonication to achieve 25 6
3% (mean 6 SD) of this maximal output during the entire
sonication time (124 6 15 W). Because this energy is emitted
vertically from the circular 0.5-in. horn tip, the output from the
horn tip was estimated to be 98 6 11 W/cm2. The mean
microbubble size of PESDA using this method has been shown
(2) to be 4.7 6 0.2 mm, with a mean concentration of 1.3 6
0.1 3 109 microbubbles/ml.
Study patients. This study included 28 patients (mean age
61 6 12 years, range 39 to 82; 18 men, 10 women [36%]) who
were undergoing stress echocardiography and who agreed to
also undergo a rest thallium uptake and dipyridamole stress
dual-isotope study (stress sestamibi/rest thallium) at the Uni-
versity of Nebraska Medical Center. The patients were se-
lected from the routine cohort of patients undergoing stress
echocardiographic studies. There were no differences in age
(61 6 12 years for both those in the study and those patients
not in the study undergoing stress echocardiography in a
similar time period) or gender (45% women from patients not
in the study). However, the study group had a higher incidence
of abnormal study results (16 [57%] of 28 had a fixed or
inducible abnormality vs. 20 [38%] of 53 with stress echocar-
diographic abnormalities in a similar time period). Left ven-
tricular systolic function at rest was normal in 19 (68%) of 28
study patients and 42 (79%) of 53 of patients undergoing stress
echocardiography in a similar time period.
Contrast echocardiography was performed the same day as
dipyridamole stress dual-radioisotope studies in 25 patients,
and within 1 week of the rest thallium studies (n 5 3). The
indications for the stress studies were evaluation of symptoms
suggestive of coronary artery disease in all patients. The rest
studies were all done in patients with a previous myocardial
infarction (two inferoposterior, one anteroseptal). All patients
provided written informed consent, and the entire protocol was
approved by the Institutional Review Board of the University
of Nebraska Medical Center, as well as the Food and Drug
Administration as an Investigational Device Exemption.
Ultrasound image acquisition and analysis of contrast
intensity. Ultrasound images were obtained with the use of a
prototype harmonic transducer (Hewlett-Packard) that was
available on a limited basis. Harmonic imaging has been shown
(1,2) to significantly enhance the improvement in myocardial
contrast achieved with transient response imaging. The trans-
mit frequency was 2.0 MHz (4.0-MHz received frequency) for
all studies.
In this study, the primary view was defined as the first
standard ultrasound window (usually the parasternal short-axis
or apical four-chamber view) being imaged after intravenous
injection of PESDA. These primary views were chosen mainly
because they would make it easiest to switch to other views
after the peak period of contrast in the myocardium. Echocar-
diograms from the primary view were routinely obtained by
triggering ultrasound transmission once per cardiac cycle (end-
systole). The background-subtracted peak myocardial video
intensity at end-systole observed with this triggering technique
has correlated closely with coronary blood flow changes in
animals (1). After obtaining primary views, secondary views
were obtained by switching back to conventional 30-Hz frame
rates and obtaining a second window (Fig. 1). The ultrasound
frame rate was then switched initially back to one frame every
cardiac cycle and then to once every three to five cardiac cycles.
If triggering once every three to five cycles produced myocar-
dial contrast enhancement, it was utilized to measure peak
myocardial videointensity (PMVI) in this view. If this trigger-
ing did not produce sufficient enhancement, it was reduced to
once every 10 cardiac cycles, and PMVI was measured with this
frame rate interval. This same protocol was then used to obtain
myocardial contrast in a third, or tertiary, view, if possible (Fig.
1). The terms “one frame every multiple cardiac cycles” or
“extended time intervals between frames” will subsequently be
used to refer to this process.
Quantitative measurements of myocardial contrast were
performed off-line from high fidelity videotape images. Myo-
cardial videointensity was measured using gray-scale software
(Tom-Tec Review Station) that quantitates videointensity
(scale of 1 to 255) versus time. PMVI from the anteroseptal,
inferoposterior, lateral and apical regions (four regions per
injection) was measured in both the primary view and from the
secondary and tertiary views using a 30-pixel region of interest
placed in the mid or distal portion of each region. The apical
region of interest was placed in the middle of the end-systolic
apical myocardial segment (Fig. 2). Images were manually
aligned before analysis of video intensity to correct for heart
motion due to respiration. If the PMVI was measured in more
than one view (e.g., anteroseptal region in the parasternal
short-axis view and then again in the parasternal or apical
Abbreviations and Acronyms
PESDA 5 perfluorocarbon-exposed sonicated dextrose albumin
PMVI 5 peak myocardial videointensity
SPECT 5 single-photon emission computed tomography (tomographic)
Figure 1. Schematic for the acquisition of myocardial contrast images
after one intravenous injection of PESDA. Myocardial contrast in the
second (20) and third (30) views was obtained by switching from
conventional (30 Hz) frame rates to one frame rate every multiple
cardiac cycles. See text for details. CI 5 conventional imaging; IVI
PESDA 5 time at which intravenous injection of perfluorocarbon-
exposed sonicated dextrose albumin was given; 10 5 first; 1:MTR 5
triggering ultrasound frame rates to one point every 5 to 10 cardiac
cycles; 1:1 TR 5 triggering ultrasound frame rates to one point every
cardiac cycle.
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long-axis view), the highest background-subtracted video in-
tensity was used for comparison with quantitative thallium
uptake. PMVI in secondary and tertiary views was measured
using the myocardial videointensity during 30-Hz frame rate
imaging as background intensity because no myocardial con-
trast was evident at this frame rate in these views. Instrumen-
tation settings (transmit power, time and lateral gain compen-
sation) were kept constant when switching to different views.
The PMVI ratio was calculated for all studies by dividing the
PMVI in the region with the lowest quantitative tracer uptake
by the PMVI in the region with highest tracer uptake.
Visual grading of myocardial contrast enhancement pro-
duced by transient response imaging in each of these views was
also assessed by two independent reviewers (T.R.P., S.L.).
Each reviewer evaluated whether the regional myocardial
contrast produced after one intravenous injection of PESDA
was normal or abnormal in the primary, secondary or tertiary
views. A visually evident contrast defect was considered present
when there was either 1) a relative decrease in contrast
enhancement in one region compared with others in the
primary view; or 2) a lack of contrast enhancement in one
region compared with others in the secondary or tertiary views
when switching from triggering once every one cardiac cycle to
once every multiple cardiac cycles. Interobserver and intraob-
server variability in image interpretation of visual myocardial
contrast was calculated by comparing the percent agreement
between the two independent observations in all patients.
Acquisition and quantitative interpretation of rest thallium
stress sestambi images. To test the validity of the myocardial
contrast observed with triggered imaging, we performed rest
thallium studies in 26 patients on the same day as their contrast
injections. The remaining two patients had rest thallium stud-
ies performed within 1 week of the rest contrast injections.
After an overnight fast, patients received an injection of 3 to
4 mCi of thallium-201 on the same day as the ultrasound
contrast studies. One patient received 8 mCi of technetium
(Tc)-99m sestamibi (Cardiolyte). Twenty-five patients received
a 20- to 25-mCi injection of Tc-99m sestamibi at peak dipyr-
idamole stress (3 min after completion of a 4-min 0.56-mg/kg
body weight infusion). SPECT images were obtained after
10 min for thallium and after 30 min for Tc-99m sestamibi
injections. A triple-headed rotating gamma camera (Picker
3000) equipped with a low energy, high resolution parallel-hole
collimator was used and centered on 73- and 166-keV photo-
peaks with 30% and 20% windows, respectively, for thallium
studies and 140-keV photo peaks with a 15% bandwidth for
Tc-99m studies. The triple-headed camera was rotated over a
1208 arc at 38 increments for 25 s each. This combined rest
thallium and dipyridamole stress SPECT sestamibi protocol
has been demonstrated (5) to have high sensitivity and speci-
ficity for detection of angiographically significant coronary
artery disease in patients with a low or intermediate probability
of having disease. Furthermore, this sequence of injections
(rest thallium followed by stress sestamibi) was utilized be-
Figure 2. Myocardial contrast enhancement in the apex,
septum and lateral walls in a patient who exhibited normal
contrast enhancement with transient response imaging in
the primary view (apical four chamber). This patient also
had normal tracer activity in these regions. IV 5 intrave-
nous; MVI 5 myocardial videointensity; p 5 after; other
abbreviations as in Figure 1.
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cause there is minimal crosstalk (,4%) of thallium into the
sestamibi window when given in this order (6).
From the raw scintigraphic data, the rest and stress images
were reconstructed by backprojections using a low pass ramp
filter. The images were oriented in the three standard orthog-
onal planes of the left ventricle (horizontal long-axis, vertical
long-axis and short-axis views) using the Odyssey VP program.
Radioisotope uptake was quantified using a computer algo-
rithm (STEPS 10, Odyssey VP Program, Picker, Inc.), which
grades the percent uptake in each region (anteroseptal, infero-
posterior, lateral and apical) on a 1 (no uptake) to 10 scale
(maximal thallium uptake) in relation to the region of highest
uptake. Any percent uptake ,70% of the highest region was
considered abnormal, similar to previously described protocols
(7). The percent uptake in each region (anteroseptal, lateral,
inferoposterior and apical) in each individual patient was then
compared with the PMVI in each region produced with
transient response imaging.
Study protocol. After thallium acquisition at rest, de-
scribed previously, baseline intravenous injections of PESDA
were given. The starting dose of intravenous PESDA for
evaluation of myocardial contrast enhancement in multiple
views was 0.00125 ml/kg and was increased to either the
0.0025-, 0.005- or 0.01-ml/kg doses as needed to produce
myocardial contrast using the previously described triggering
protocol. Before, during and after each injection, blood pres-
sure, heart rate, oxygen saturation, respiratory rate and heart
rhythm were recorded. Any patient symptoms during and after
injection were also recorded.
Dipyridamole infusion was then initiated at a rate of
0.14 mg/kg per min over 4 min or up to a maximal dose of
60 mg. At 6 and 8 min after completion of the dipyridamole
infusion, respectively, two repeat doses of intravenous PESDA
(using the same dose as the baseline injection) were given, and
the imaging protocol shown in Figure 1 was repeated. At 7 min
after the initiation of dipyridamole, 20 to 25 mCi of sestamibi
was given for subsequent SPECT images using the previously
described protocol.
Statistical analysis. Differences in PMVI ratios in the
patients with normal findings on dual-isotope imaging ($70%
uptake in all regions) and patients that had either fixed or
inducible defects by dual-isotope imaging were compared with
analysis of variance (Student-Newmann-Keuls multiple com-
parison procedure). A p value ,0.05 was considered signifi-
cant. The Pearson correlation coefficient was used to deter-
mine the correlation between each patient’s regional PMVI
and regional quantitative thallium or sestamibi uptake. Both
interobserver and intraobserver agreement on PMVI measure-
ments in the different regions were compared by computing
the standard deviation of 45 measurements made by the two
different observers divided by the mean PMVI measured by
both observers (coefficient of variation). Injection to injection
variability was also calculated by repeating the same PMVI
measurements in the primary, secondary and tertiary views in
21 regions of seven patients after a second injection of the
same intravenous dose of PESDA.
Results
The dose of intravenous PESDA used to produce myocar-
dial contrast was 0.00125 ml/kg in 6 patients, 0.0025 ml/kg in
18, 0.005 ml/kg in 2 and 0.01 ml/kg in 2. The primary view was
either the parasternal short-axis (after 30 injections) or apical
four-chamber view (20 injections). The apical two-chamber
view was the primary view in one patient and the apical
long-axis view in two patients. Myocardial contrast could be
visually observed by both reviewers in all 28 patients when
triggered imaging was used. With this technique myocardial
contrast enhancement was visually evident in at least three
different windows with one intravenous injection of contrast
agent in 26 of 28 patients and in two views in all patients.
Myocardial contrast in the second and third views was
evident only when extended time intervals between frame rates
were used. In 21 patients, production of myocardial contrast
required one frame every three to five cardiac cycles in the
secondary and tertiary views, whereas contrast enhancement
was not achieved in the remaining 7 until the frame rate was
reduced to once every 10 cardiac cycles. Of the 89 regions that
were compared twice (at rest and again during dipyridamole
stress), 51 had PMVI measured from the same view (primary,
secondary or tertiary) at rest and during stress. In the remain-
ing 38 regions, rest PMVI measurements were obtained using
a different view from that used during dipyridamole stress.
Seven regions in six patients (lateral in five, inferoposterior in
two) could not be assessed because of persistent attenuation of
this region in all views and at all frame rates.
Dipyridamole infusion induced a slight increase in heart
rate in the 25 patients studied (67 6 12 to 81 6 13 beats/min)
and a slight decrease in systolic blood pressure (from 141 6
23 mm Hg at rest to 132 6 19 mm Hg after dipyridamole).
There was no significant change in diastolic blood pressure
(from 79 6 11 mm Hg at rest to 77 6 18 mm Hg after
dipyridamole).
Correlation between myocardial contrast observed with
transient response imaging and tracer uptake. Of 25 patients
with both rest and dipyridamole stress studies, 5 patients had
quantitative evidence of a defect present at rest and during
stress with dual-isotope imaging (,70% uptake at rest and
during stress; inferoposterior region in 4, lateral region in 1).
Ten regions in eight patients exhibited new uptake abnormal-
ities during dipyridamole infusion (inferoposterior in 5, lateral
in 1, anteroseptal in 3, apical in 1). One patient had a mild
decreased uptake of thallium (60%) at rest that was quantita-
tively normal during dipyridamole stress. The remaining re-
gions were quantitatively normal ($70% uptake) during both
rest thallium and stress sestamibi. In the three patients with
rest thallium studies only, uptake abnormalities in the antero-
septal, apical and inferoposterior regions were present in one
and inferoposterior uptake abnormalities in the other two.
Therefore, there was an overall total of 11 regional uptake
abnormalities at rest and 15 uptake abnormalities during
dipyridamole stress. One patient with a rest inferoposterior
thallium defect could not be evaluated with transient response
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imaging because of persistent inferoposterior attenuation after
intravenous PESDA. Thus, 10 rest and 15 stress tracer uptake
abnormalities remained for comparison studies.
The PMVI ratio produced with transient response imaging
in the regions that exhibited both normal rest and normal
dipyridamole tracer uptake was 0.76 6 14 at rest and did not
change during dipyridamole stress (0.70 6 0.11). Figure 2 is an
example from the apical four-chamber view (primary view) of
a patient with both normal contrast enhancement at rest and
normal thallium uptake. Figure 3 demonstrates normal con-
trast enhancement in another patient at rest and during
dipyridamole stress from the parasternal short-axis view (pri-
mary view in this patient).
In the regions with stress-induced tracer uptake abnormal-
ities, the PMVI ratio decreased significantly during stress
(from 0.78 6 18 U baseline to 0.41 6 0.20 U during dipyrid-
amole stress, p , 0.05). In regions that had quantitatively
abnormal tracer uptake both at rest and during stress, there
was a significantly lower PMVI ratio during both rest studies
(0.48 6 0.14) and dipyridamole stress (0.35 6 0.11). This ratio
decreased slightly during dipyridamole stress and corre-
sponded to a decrease in nuclear tracer activity in this region.
Overall, a PMVI ratio.0.6 was seen in 154 of 168 regions that
had normal tracer uptake at rest or during dipyridamole stress.
In comparison, only 3 of the 25 abnormal regions had
.0.6 PMVI ratio during rest or stress. Therefore, the sensitiv-
ity and specificity of a PMVI ratio ,0.6 in detecting an
abnormal tracer uptake at rest or during dipyridamole stress
were 92% and 84%, respectively.
Table 1 compares the ability of visual analysis and measure-
ment of a PMVI ratio ,0.6 in any view after intravenous
PESDA to detect perfusion abnormalities in patients with
either a rest or stress-induced tracer uptake abnormality
,70%. A PMVI ratio ,0.6 was seen in 22 of the 25 regions
with either a thallium or sestamibi uptake ,70%. In compar-
ison, a visually evident myocardial contrast abnormality was
identified by at least one of the reviewers in only 12 of the 25
regions with tracer uptake abnormalities (Table 1).
On a patient by patient basis, there was good correlation
between regional thallium uptake (anteroseptal, lateral, in-
feroposterior and apical regions) and regional PMVI at rest
(mean r value 0.84, range 0.53 to 0.97). The correlation
between regional sestamibi uptake and regional PMVI during
dipyridamole stress was also good, with a mean correlation
coefficient of 0.88 (range 0.77 to 0.99). Figure 4 demonstrates
an inferoposterior defect during dipyridamole stress seen in a
secondary view (parasternal long axis) that was visually and
quantifiably evident only with one frame every multiple cardiac
cycles. Figure 5 illustrates an anteroseptal contrast defect seen
in the apical long-axis image using an extended time interval
between frame rates. This was the tertiary view both at rest and
during dipyridamole stress in this patient. The secondary or
tertiary view was required to either detect or confirm the
perfusion abnormality in 15 contrast defects (4 during rest, 11
during stress).
The interobserver variability formeasurements of background-
subtracted PMVI was 18.8%, with a correlation coefficient
between the two observers of 0.91 (SE 12 U). Intraobserver
variability for PMVI measurements was 14%, with a correla-
tion coefficient between the two measurements of 0.96 (SE
8 U). The injection to injection variability in PMVI measure-
ments was 13%, with a correlation between the PMVI mea-
surements from two separate injections of 0.97 (SE 7 U).
These are all well below the 32% difference in PMVI from
baseline to peak dipyridamole stress in normal regions and the
59% difference in PMVI that we observed between normal and
abnormal regions during dipyridamole stress. The percent
agreement between the two independent observers on whether
myocardial contrast enhancement was visually normal or ab-
normal in the 25 patients undergoing rest and stress contrast
studies was 93%.
Discussion
This study demonstrated two important advances in the
noninvasive assessment of myocardial perfusion with intrave-
nous ultrasound contrast: 1) We could detect myocardial
contrast enhancement in multiple views with one intravenous
Figure 3. Myocardial contrast enhancement from the parasternal
short-axis view in another patient (primary view in this patient).
Arrows enclosing endocardial and epicardial borders depict normal
contrast enhancement under rest conditions and during peak dipyrid-
amole stress. The corresponding stress tracer uptake is also shown and
was also quantitatively normal. DIPY 5 images obtained during
dipyridamole stress; TRI5 triggered imaging (one frame every cardiac
cycle in this primary view).
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injection of PESDA in the majority of patients when using
harmonic transient response imaging with an extended time
interval between frame rates. 2) We observed close agreement
between quantitative thallium and sestamibi uptake and re-
gional PMVI measured with transient response imaging at rest
and during dipyridamole stress. The sensitivity of PMVI
measurements was better than visual analysis in differentiating
regions with normal and abnormal tracer uptake. These two
findings demonstrate the potential of harmonic transient re-
sponse imaging for the noninvasive detection of myocardial
perfusion abnormalities in humans in a wide variety of clinical
settings.
Optimizing detection of myocardial contrast with transient
response imaging. Visually evident myocardial contrast was
produced with transient response imaging in secondary and
tertiary views in the majority of patients by prolonging the time
interval between frame rates. The reason for this prolonged
myocardial contrast can be attributed to two factors: 1) pro-
longed pulmonary “hangup” of PESDAmicrobubbles, creating
a situation in which a continuous infusion of microbubbles into
the left ventricular cavity occurs; and 2) the ability of transient
response imaging to still detect these smaller concentrations of
fluorocarbon-containing microbubbles as they pass through the
myocardial microcirculation.
The lungs appear to act as a filter or “sieve” when large
concentrations of microbubbles enter the pulmonary circula-
tion (8,9). They not only prevent the passage of bubbles that
are .8 mm from reaching the left atrium, but also delay the
passage of smaller microbubbles (8). This filtering mechanism
may transiently become defective with the initial bolus of
microbubbles, briefly allowing a larger volume of bubbles into
the left ventricular cavity (10). However, after this initial bolus
effect, the remaining microbubbles transit at a slower rate,
sometimes taking up to an entire circulation time to pass
through the pulmonary circuit (8). This prolonged left ventric-
ular cavity contrast was most likely not due to recirculation
because of its continuous nature. With recirculation, one
would expect a disappearance of left ventricular cavity contrast
and reappearance. Furthermore, no reentry of microbubbles
into the right ventricular cavity was ever observed.
Reducing the ultrasound frame rate or pulse repetition
frequency has been shown (11,12) to prevent the destruction of
PESDA microbubbles. When triggering at one frame every
cardiac cycle, we observed a significant increase in PMVI in
normally perfused regions immediately after injection that
would not have been observed with a more rapid frame rate
(13). This increase corresponded to the initial bolus of micro-
bubbles reaching the left ventricular cavity from the pulmonary
circulation. Although the concentration of microbubbles
reaching the left ventricular cavity after this initial bolus began
decreasing as the lung regained its filtering capabilities, the
ratio of microbubbles reaching each perfusion bed did not
change. Because a more prolonged time interval between
frame rates should destroy even fewer microbubbles than one
frame every cardiac cycle, the end result was an equivalent
degree of myocardial contrast enhancement in the secondary
and tertiary views comparable to that seen with the initial bolus
Table 1. Comparison of Nuclear Imaging and Transient Response Imaging in Detecting Perfusion Abnormalities*
Pt No./
Gender
Age
(yr)
ND
Location Timing
Quantitative Visual
PMVI
Ratio ,0.6 Location Timing
Visual
MCD Location Timing
1/M 63 IP Stress only Yes IP Stress only Yes IP Stress only
2/M 65 AS Stress only Yes AS Stress only No — —
IP Stress only No — No — —
3/M 53 IP R1S Yes IP R1S Yes IP R1S
4/M 58 AS Stress only Yes AS Stress only Yes AS/apex R1S
5/F 51 AS Stress only Yes AS/apex R1S Yes Apex only R1S
Lat R1S Yes Lat R1S No — —
6/M 73 IP Rest only Yes IP Rest only No — —
7/M 73 IP R1S Yes IP R1S Yes IP R1S
8/M 71 IP R1S Yes IP R1S No — —
9/F 68 Apex Stress only Yes Apex Stress only No —
10/M 78 Lat Stress only Yes Lat Stress only No —
IP Stress only Yes IP Stress only Yes IP R1S
11/M 79 IP Stress only No — — No IP
12/M 64 IP R1S Yes IP R1S No —
13/F 62 IP Stress only Yes IP R1S Yes IP R1S
14/M 55 AS/apex Rest only Yes AS Rest only Yes AS Rest only
Apex Rest only Yes Apex Rest only Yes Apex Rest only
IP Rest only No — — Yes IP Rest only
15/M 54 IP Rest only Yes IP/Lat Rest only Yes IP Rest only
*A total of 25 nuclear perfusion defects were identified (10 rest, 15 stress). AS5 anteroseptum; F5 female; IP5 inferoposterior; Lat5 lateral; M5male; MCD5
myocardial contrast defect; ND 5 nuclear defect; PMVI5 peak myocardial videointensity with transient response imaging after intravenous perfluorocarbon-exposed
sonicated dextrose albumin; Pt 5 patient; R1S 5 rest and dipyridamole stress; — 5 no defect by this method.
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effect when perfusion was normal. This is exemplified in the
normal regions shown graphically in Figures 4 and 5.
This increase in myocardial contrast when switching to one
frame every multiple cardiac cycles did not occur in regions
that had abnormal perfusion by dual-isotope imaging. In the 15
of the 25 quantitatively abnormal regions by dual-isotope
imaging, the myocardial contrast defects were either visualized
better or quantified in a secondary or tertiary view using this
technique. The effect of extended time intervals between frame
rates in quantifying these perfusion abnormalities is evident in
the plots of PMVI versus time using different frame rates in
Figures 4 and 5.
Measuring the peak myocardial contrast enhancement in
each view was more sensitive than visual analysis in detecting
tracer uptake abnormalities for at least two reasons: 1) we used
only a gray scale to visually assess contrast enhancement. The
human eye is incapable of accurately differentiating different
shades of gray. Color-coded images have been shown (14) to
produce more visually apparent regional differences in myo-
cardial contrast enhancement, especially when using a map
that reflects the color changes that occur in a progressively
heated object. 2) Visual detection of myocardial contrast
defects may have been improved had we used digital subtrac-
tion of the precontrast images, as has been done elsewhere
(14). Since we could do this when measuring PMVI in both
primary and secondary or tertiary views (by subtracting back-
ground videointensity), a more subtle difference in regional
contrast enhancement was apparent with the quantitative
analysis.
Differences in regional PMVI and regional tracer uptake
during dipyridamole stress. PMVI changes during any inter-
vention have been shown (15) to reflect changes in myocardial
blood volume. However, changes in thallium or sestamibi
uptake correlate with changes in myocardial blood flow. Myo-
cardial blood volume changes correlate with flow changes only
when autoregulation is preserved. During vasodilator stress,
autoregulation may be abolished, leading to situations where
flow changes may exceed volume changes (14). In this setting,
the ratio of PMVI between a stenotic zone and a normally
perfused zone has still been shown (16,17) to correlate with
myocardial blood flow changes measured with radioactive
microspheres. In our patients, we also observed good agree-
ment between the PMVI ratios and regional thallium uptake at
rest and during maximal vasodilator stress. Furthermore, there
was good direct correlation in individual patients between
PMVI obtained in the four different regions and tracer uptake
in these same regions, both at rest and during vasodilator
stress.
Limitations of the study. Although extended time intervals
between frame rates produced prolonged myocardial contrast
after very low doses of intravenous PESDA in our patients, it
may be impractical in some patients to hold a transducer in one
Figure 4. Example of a contrast defect in a second-
ary view (parasternal long axis) during dipyridamole
stress in a patient who also exhibited quantitatively
abnormal nuclear study results (Dipy Nuclear im-
age). As can be seen, this defect was visually more
evident when using an extended time interval be-
tween frame rates (right panel) because of lack of
contrast enhancement in the posterior wall (arrows)
when switching from triggering ultrasound frame
rates to one point every cardiac cycle (1:TR) to once
every multiple cardiac cycles (1:MTR). CI 5 con-
ventional imaging; MVI 5 myocardial videointen-
sity.
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position for this period of time. Another limitation with
triggering frame rates to produce better myocardial contrast is
that wall motion throughout the cardiac cycle cannot be
observed while assessing perfusion. Modifications in trans-
ducer design may be possible that would improve microbubble
survival and hence produce increased contrast without requir-
ing the long time interval between frame rates. This may
involve altering the pulse duration as well as acoustic output
because both affect how a given ultrasound pulse interacts with
microbubbles (18). Another method that would increase the
number of views in which myocardial contrast could be ob-
served with triggered imaging would be to give repeated
smaller boluses of contrast intravenously when switching to
different views. The bolus effect of intravenous contrast that
was typically seen in the primary view after injection in our
study could then be observed in other views as well. However,
repeated boluses may increase the degree of attenuation of
more distal regions in the basal and inferoposterior myocar-
dium.
Attenuation due to left ventricular cavity contrast may
make it difficult to distinguish between truly abnormal perfu-
sion and attenuation in the inferior and posterior regions even
with triggered imaging and low doses of intravenous contrast.
However, the present study emphasizes that the best way to
overcome this problem is by using extended time intervals
between frame rates after the initial bolus of contrast agent in
the left ventricular cavity. Even with a very small intravenous
injection of PESDA, there is some attenuation of more distal
myocardium with the initial bolus entry of contrast agent into
the left ventricular cavity. However, once this bolus has
resolved, we found that failure of inferoposterior myocardium
to enhance with one frame every 10 cardiac cycles (as demon-
strated in Fig. 4) was a much more reliable way of detecting
abnormal perfusion compared with dual-isotope imaging. The
normal posterior myocardium enhances with this technique, as
demonstrated in Figure 5.
Clinical implications. To our knowledge, this is the first
study to demonstrate that rest and stress-induced myocardial
perfusion abnormalities can be detected using transient re-
sponse imaging in multiple views with one dose of intravenous
microbubbles in humans. This study also demonstrated that
regional PMVI produced with transient response imaging both
at rest and during dipyridamole stress correlates closely with
regional rest thallium and dipyridamole sestamibi uptake.
Because triggered imaging can be rapidly performed at the
patient’s bedside at rest and during stress, transient response
imaging may be a cost-effective and accurate method of
detecting perfusion abnormalities in humans. This imaging
technique should be applicable to other microbubbles as well,
especially the fluorocarbon-encapsulated microbubbles (19–
21). Larger studies are now needed with these different agents
to evaluate the incremental benefit of this technique over
currently available ultrasound techniques, such as wall motion
analysis, in improving the detection and quantification of
myocardial ischemia.
Figure 5. Apical long-axis view (tertiary view)
in a patient who had both visual and quanti-
tative evidence of an anteroseptal contrast
defect (arrows) at rest and during dipyrida-
mole (Dipy) stress when an extended time
interval between frame rates was used. Note
the abnormal enhancement in myocardial
videointensity in the anteroseptal region
when switching triggering ultrasound frame
rates to one point every multiple cardiac
cycles compared with that in the apical and
posterior regions. However, the nuclear de-
fect in this region was abnormal only during
stress. Abbreviations as in as Figure 4.
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